N-methyl-D-aspartate receptor subtypes:: Multiple roles in excitotoxicity and neurological disease

被引:294
作者
Waxman, EA
Lynch, DR
机构
[1] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
关键词
NMDA; excitotoxicity; NR2A; NR2B; Huntington's disease; Parkinson's disease; epilepsy; MAPK; Calpain; Calmodulin;
D O I
10.1177/1073858404269012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
N-methyl-D-aspartate (NMDA) receptors are the major mediator of excitotoxicity. Although physiological activation of the NMDA receptor is necessary for cell survival, overactivation is a signal for cell death. Several pathways are activated through NMDA receptor stimulation. most of which can contribute to excitotoxicity. These include events leading to mitochondrial dysfunction, activation of calcium-dependent enzymes, and activation of mitogen-activated protein kinase pathways. Understanding the role of these mechanisms is important in developing agents that block excitotoxicity without inhibiting functions necessary for survival. NMDA receptor subtypes may be responsible for mediating separate pathways, and subtype-specific inhibition has shown promising results in some neurological models. This review examines the roles of NMDA receptor subtypes in excitotoxicity and neurological disorders.
引用
收藏
页码:37 / 49
页数:13
相关论文
共 97 条
[1]   Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions [J].
Aarts, M ;
Liu, YT ;
Liu, LD ;
Besshoh, S ;
Arundine, M ;
Gurd, JW ;
Wang, YT ;
Salter, MW ;
Tymianski, M .
SCIENCE, 2002, 298 (5594) :846-850
[2]   5-phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition [J].
Auberson, YP ;
Allgeier, H ;
Bischoff, S ;
Lingenhoehl, K ;
Moretti, R ;
Schmutz, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) :1099-1102
[3]  
BANAGLIA G, 2002, EPILIPSIA, V43, P209
[4]  
Barone FC, 2001, J PHARMACOL EXP THER, V296, P312
[5]   Interaction with the NMDA receptor locks CaMKII in an active conformation [J].
Bayer, KU ;
De Koninck, P ;
Leonard, AS ;
Hell, JW ;
Schulman, H .
NATURE, 2001, 411 (6839) :801-805
[6]   Kindling induces transient NMDA receptor-mediated facilitation of high-frequency input in the rat dentate gyrus [J].
Behr, J ;
Heinemann, U ;
Mody, I .
JOURNAL OF NEUROPHYSIOLOGY, 2001, 85 (05) :2195-2202
[7]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[8]   N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy [J].
Brandt, C ;
Potschka, H ;
Löscher, W ;
Ebert, U .
NEUROSCIENCE, 2003, 118 (03) :727-740
[9]  
Brenman JE, 1996, J NEUROSCI, V16, P7407
[10]   Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits [J].
Chatterton, JE ;
Awobuluyi, M ;
Premkumar, LS ;
Takahashi, H ;
Talantova, M ;
Shin, Y ;
Cui, JK ;
Tu, SC ;
Kevin, ASK ;
Nakanishi, N ;
Tong, G ;
Lipton, SA ;
Zhang, DX .
NATURE, 2002, 415 (6873) :793-798